similar components (Figure 1 and Table 1).6
The next few months alone are likely to see at least five new vaccines on the U.S. market, with several more in development (Table 1).13 Maintaining public confidence to minimize vaccine hesitancy will be crucial.14,15 As in any post-EUA program, adverse events that were not iden